Related Experiment Video
Updated: Aug 14, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Treatment of Bacteroides infection with clindamycin-2-phosphate
Abstract:
Eighteen patients with serious Bacteroides infections were treated with systemic clindamycin-2-phosphate. Sixteen patients recovered without complications while two patients died. Few side effects were noted. The infections treated included septic abortion, posthysterectomy infections, pelvic inflammatory disease, perforation of the bowel, postoperative complications of abdominal surgery and pancreatic abscess. The clinical usefulness of this drug in treating Bacteroides infection is confirmed.
Insights
Systemic clindamycin-2-phosphate effectively treated serious Bacteroides infections in eighteen patients. Sixteen patients recovered fully, confirming the drug's clinical usefulness for these challenging infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Bacteroides species are significant pathogens in serious intra-abdominal and gynecological infections.
- Effective antimicrobial therapy is crucial for managing severe Bacteroides infections.
- Clindamycin-2-phosphate is a potential treatment option for these infections.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of systemic clindamycin-2-phosphate in patients with serious Bacteroides infections.
- To assess the range of infections successfully treated with clindamycin-2-phosphate.
Main Methods:
- A cohort of eighteen patients with serious Bacteroides infections was treated with systemic clindamycin-2-phosphate.
- Patient outcomes, including recovery and complications, were monitored.
- Adverse events associated with clindamycin-2-phosphate were recorded.
Main Results:
- Sixteen out of eighteen patients recovered without complications.
- Two patients treated with clindamycin-2-phosphate died.
- Few side effects were observed during the treatment period.
- Successful treatment was observed across various infections, including septic abortion, posthysterectomy infections, pelvic inflammatory disease, bowel perforation, and pancreatic abscess.
Conclusions:
- Systemic clindamycin-2-phosphate demonstrates significant clinical usefulness in treating serious Bacteroides infections.
- The drug is well-tolerated with a low incidence of side effects.
- Clindamycin-2-phosphate is a viable therapeutic option for a spectrum of severe infections caused by Bacteroides species.
More Related Videos
Related Concept Videos
Antibiotic Selection
Lytic Cycle of Bacteriophages
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Phylum Bacteroidota

